Calcium Trisodium Pentetate (Ca-DTPA) ampoules

Department of National Defence (DND)
CanadaBuys Posted: November 10, 2026

Location: Ontario, Canada

Due Date
November 25, 2026
(6 days left)
Solicitation #
W6369-27-A062

Actions

Email me bids like this (free)

Paste your website. We'll send matching US & Canadian bids every morning.

or
Or get a go/no-go analysis of this bid

Documents (1)

Downloads need a free Narwin account.

  • w6369-27-a062_ca-dtpa_acan_eng.pdf
    PDF · 117.6 KB

Description

Read full description

NOTICE OF PROPOSED PROCUREMENT The Department of National Defence (DND), through the Strategic Medical Countermeasures Program (SMCP) on behalf of the Canadian Forces Health Services Group (CF H Svcs Gp), has a requirement for the supply of Calcium Trisodium Pentetate (Ca-DTPA) ampoules for the treatment of Canadian Armed Forces (CAF) personnel who may have been exposed to radioactive contamination involving transuranic elements. The Ca-DTPA product must consist of sterile Calcium Trisodium Pentetate solution for injection, containing approximately 1,000 mg to 1,055 mg of active ingredient in a 5 mL ampoule suitable for intravenous administration. The product is intended for use as a medical countermeasure to enhance the elimination of internally deposited radioactive transuranic elements, including plutonium, americium and curium, following confirmed or suspected radiological exposure. The product must meet all applicable regulatory, quality assurance, packaging, labelling and shelf-life requirements specified in the solicitation documents. The initial requirement consists of the supply of 250 Ca-DTPA ampoules for delivery no later than 1 March 2027. The resulting contract is anticipated to be valid from contract award date to 31 March 2031 and includes additional scheduled deliveries of 250 ampoules in Fiscal Year 2027-2028 and 250 ampoules in Fiscal Year 2028-2029. The contract will also include an option for up to an additional 500 ampoules exercisable during the contract period. This procurement will be conducted through an Advance Contract Award Notice (ACAN). The Government of Canada has identified Heyl Chemisch-pharmazeutische Fabrik GmbH & Co. KG as the only supplier currently known to satisfy the operational, clinical and technical requirements associated with this requirement. Suppliers that consider themselves fully qualified and capable of meeting the complete requirement may submit a Statement of Capabilities during the posting period. The Crown retains the rights to negotiate with suppliers on any procurement. Documents may be submitted in either official language of Canada. Barring any applicable trade agreement exceptions or other legal restrictions, eligible suppliers may participate in this solicitation process. NOTE TO SUPPLIERS: Procurement Assistance Canada offers seminars to businesses interested in learning how to sell goods and services to the Government of Canada. These seminars are provided free of charge.

Additional Information

Source

canadabuys

Status

open

Procurement Method

Advance contract award notice

Procurement Category

Goods

Regions of Opportunity

Canada

Regions of Delivery

Canada

Reference Number

cb-141-88756202

Amendment Number

000

Contracting Entity

Department of National Defence (DND)

Contact Name

Eduardo Vides

Contact Email

Contact Phone

+18734697365

Contact Country

Canada

Organization City

Ottawa

Organization Province / State

Ontario

Organization Country

Canada

Last Updated

November 13, 2026

Frequently Asked Questions

When is the proposal submission deadline?

The proposal submission deadline is November 25, 2026 (6 days left).

Where can I submit a proposal or get solicitation documents?

You can access the full solicitation documents and submit your proposal at the official source:

Visit Official Source

Get new bids from this agency by email

Follow for free

Narwin checks SAM.gov, CanadaBuys, BC Bid and 50+ city portals daily and emails you only the bids that fit your business. Disclaimer: This bid/tender/opportunity information is presented as is and may be incorrect at times. Please read the tender documents carefully before finalizing bids. We do not accept any responsibility and cannot be held legally liable for any inaccuracies.